» Articles » PMID: 39651978

7. Diabetes Technology: Standards of Care in Diabetes-2025

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2024 Dec 9
PMID 39651978
Affiliations
Soon will be listed here.
Abstract

The American Diabetes Association (ADA) "Standards of Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

Citing Articles

Comprehensive Assessment of Neuropathy and Metabolic Parameters in Type 1 Diabetic Patients with or Without Using Continuous Glucose Sensors.

Bordacs B, Varkonyi A, Valkusz Z, Nyiraty S, Posa A, Menyhart A Int J Mol Sci. 2025; 26(5).

PMID: 40076685 PMC: 11900075. DOI: 10.3390/ijms26052062.


Personality in Type 1 Diabetes and the Impact of Personality Traits on the Effects of Introducing Diabetes Technology.

Secher A, Nexo M, Mortensen E, Norgaard K Psychol Res Behav Manag. 2025; 18:353-360.

PMID: 40008247 PMC: 11853824. DOI: 10.2147/PRBM.S492084.

References
1.
Wong J, Boyle C, DiMeglio L, Mastrandrea L, Abel K, Cengiz E . Evaluation of Pump Discontinuation and Associated Factors in the T1D Exchange Clinic Registry. J Diabetes Sci Technol. 2016; 11(2):224-232. PMC: 5478021. DOI: 10.1177/1932296816663963. View

2.
Wood M, Shulman D, Forlenza G, Bode B, Pinhas-Hamiel O, Buckingham B . In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes. Diabetes Technol Ther. 2018; 20(11):731-737. DOI: 10.1089/dia.2018.0209. View

3.
Martens T, Beck R, Bailey R, Ruedy K, Calhoun P, Peters A . Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021; 325(22):2262-2272. PMC: 8173473. DOI: 10.1001/jama.2021.7444. View

4.
Frid A, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch L . New Insulin Delivery Recommendations. Mayo Clin Proc. 2016; 91(9):1231-55. DOI: 10.1016/j.mayocp.2016.06.010. View

5.
Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View